|
Originally published In Press as doi:10.1074/jbc.M909536199 on March 31, 2000
J. Biol. Chem., Vol. 275, Issue 24, 18358-18365, June 16, 2000
Identification of Transacting Factors Responsible for the
Tissue-specific Expression of Human Glucose Transporter Type 2 Isoform Gene
COOPERATIVE ROLE OF HEPATOCYTE NUCLEAR FACTORS 1 AND
3 *
Ji-Young
Cha ,
Ha-il
Kim ,
Kyung-Sup
Kim,
Man-Wook
Hur, and
Yong-ho
Ahn§
From the Department of Biochemistry and Molecular Biology and the
Institute of Genetic Science, Yonsei University College of
Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, South
Korea
We investigated transacting factors binding to
the cis-element important in tissue-specific expression of the human
glucose transporter type 2 isoform (GLUT2) gene. By transient
transfection assay, we determined that the 227-base pair fragment
upstream of the ATG start site contained promoter activity and that the region from +87 to +132 (site C) was responsible for tissue-specific expression. DNase I footprinting and electrophoretic mobility shift
assay indicated that site C contained one binding site for hepatocyte
nuclear factor 1 (HNF1) and two binding sites for HNF3. The mutations
at positions +101 and +103, which are considered to be critical in
binding HNF1 and HNF3, resulted in a 53% decrease in promoter
activity, whereas the mutation of the proximal HNF3 binding site (+115
and +117) reduced promoter activity by 28%. The mutations of these
four sites resulted in marked decrease (70%) in promoter activity as
well as diminished bindings of HNF1 and HNF3. A to G mutation, which
causes conversion of the HNF1 and HNF3 binding sequence to the NF-Y
binding site, resulted in a 22% decrease in promoter activity. We
identified that both HNF1 and HNF3 function as transcriptional
activators in GLUT2 gene expression. Coexpression of the pGL+74 (+74 to
+301) construct with the HNF1 and HNF3 expression vectors in NIH
3T3 cells showed the synergistic effect on GLUT2 promoter activity
compared with the expression of HNF1 , HNF3 , or a combination of
HNF1 and HNF3 . These data suggest that HNF1 and HNF3 may be
the most important players in the tissue-specific expression of the
human GLUT2 gene.
*
This work was supported by Korea Science and Engineering
Foundation Grant 96-0403-14-01-3.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Recipient of a scholarship from the Brain Korea 21 Project For
Medical Science, Ministry of Education, South Korea.
§
To whom correspondence should be addressed: Dept. of Biochemistry
and Molecular Biology, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea. Tel.:
82-2-361-5187; Fax: 82-2-312-5041; E-mail:
yha111@yumc.yonsei.ac.kr.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Dos Santos, P. Bougneres, and D. Fradin
A Single-Nucleotide Polymorphism in a Methylatable Foxa2 Binding Site of the G6PC2 Promoter Is Associated With Insulin Secretion In Vivo and Increased Promoter Activity In Vitro
Diabetes,
February 1, 2009;
58(2):
489 - 492.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Wederell, M. Bilenky, R. Cullum, N. Thiessen, M. Dagpinar, A. Delaney, R. Varhol, Y. Zhao, T. Zeng, B. Bernier, et al.
Global analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencing
Nucleic Acids Res.,
August 1, 2008;
36(14):
4549 - 4564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Freitas, G. F. Anhe, K. F. S. Melo, M. M. Okamoto, M. Oliveira-Souza, S. Bordin, and U. F. Machado
Na+-Glucose Transporter-2 Messenger Ribonucleic Acid Expression in Kidney of Diabetic Rats Correlates with Glycemic Levels: Involvement of Hepatocyte Nuclear Factor-1{alpha} Expression and Activity
Endocrinology,
February 1, 2008;
149(2):
717 - 724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E Cerf
Transcription factors regulating {beta}-cell function.
Eur. J. Endocrinol.,
November 1, 2006;
155(5):
671 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Haumaitre, M. Fabre, S. Cormier, C. Baumann, A.-L. Delezoide, and S. Cereghini
Severe pancreas hypoplasia and multicystic renal dysplasia in two human fetuses carrying novel HNF1{beta}/MODY5 mutations
Hum. Mol. Genet.,
August 1, 2006;
15(15):
2363 - 2375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-S. Im, S.-Y. Kang, S.-Y. Kim, H.-i. Kim, J.-W. Kim, K.-S. Kim, and Y.-H. Ahn
Glucose-Stimulated Upregulation of GLUT2 Gene Is Mediated by Sterol Response Element-Binding Protein-1c in the Hepatocytes
Diabetes,
June 1, 2005;
54(6):
1684 - 1691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Winzell, G. Pacini, C. B. Wollheim, and B. Ahren
Beta-Cell-Targeted Expression of a Dominant-Negative Mutant of Hepatocyte Nuclear Factor-1{alpha} in Mice: Diabetes Model with {beta}-Cell Dysfunction Partially Rescued by Nonglucose Secretagogues
Diabetes,
December 1, 2004;
53(suppl_3):
S92 - S96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-Y. Kim, H.-i. Kim, T.-H. Kim, S.-S. Im, S.-K. Park, I.-K. Lee, K.-S. Kim, and Y.-H. Ahn
SREBP-1c Mediates the Insulin-dependent Hepatic Glucokinase Expression
J. Biol. Chem.,
July 16, 2004;
279(29):
30823 - 30829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Divine, S. P. McCaul, and T. C. Simon
HNF-1{alpha} and endodermal transcription factors cooperatively activate Fabpl: MODY3 mutations abrogate cooperativity
Am J Physiol Gastrointest Liver Physiol,
June 9, 2003;
285(1):
G62 - G72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Melloul, S. Marshak, and E. Cerasi
Regulation of pdx-1 Gene Expression
Diabetes,
December 1, 2002;
51(90003):
S320 - 325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Bai, M. Pontoglio, T. Hiesberger, A. M. Sinclair, and P. Igarashi
Regulation of kidney-specific Ksp-cadherin gene promoter by hepatocyte nuclear factor-1beta
Am J Physiol Renal Physiol,
October 1, 2002;
283(4):
F839 - F851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-K. Lee, D. Suh, H. J. Edenberg, and M.-W. Hur
POZ Domain Transcription Factor, FBI-1, Represses Transcription of ADH5/FDH by Interacting with the Zinc Finger and Interfering with DNA Binding Activity of Sp1
J. Biol. Chem.,
July 19, 2002;
277(30):
26761 - 26768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ban, Y. Yamada, Y. Someya, K. Miyawaki, Y. Ihara, M. Hosokawa, S. Toyokuni, K. Tsuda, and Y. Seino
Hepatocyte Nuclear Factor-1{alpha} Recruits the Transcriptional Co-Activator p300 on the GLUT2 Gene Promoter
Diabetes,
May 1, 2002;
51(5):
1409 - 1418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-y. Cha, H.-s. Kim, H.-i. Kim, S.-s. Im, S.-y. Kim, J.-w. Kim, B.-i. Yeh, and Y.-h. Ahn
Analysis of Polymorphism of the GLUT2 Promoter in NIDDM Patients and its Functional Consequence to the Promoter Activity
Ann. Clin. Lab. Sci.,
April 1, 2002;
32(2):
114 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Hagenfeldt-Johansson, P. L. Herrera, H. Wang, A. Gjinovci, H. Ishihara, and C. B. Wollheim
{beta}-Cell-Targeted Expression of a Dominant-Negative Hepatocyte Nuclear Factor-1{alpha} Induces a Maturity-Onset Diabetes of the Young (MODY)3-Like Phenotype in Transgenic Mice
Endocrinology,
December 1, 2001;
142(12):
5311 - 5320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Shen, L. M. Scearce, J. E. Brestelli, N. J. Sund, and K. H. Kaestner
Foxa3 (Hepatocyte Nuclear Factor 3gamma ) Is Required for the Regulation of Hepatic GLUT2 Expression and the Maintenance of Glucose Homeostasis during a Prolonged Fast
J. Biol. Chem.,
November 9, 2001;
276(46):
42812 - 42817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Párrizas, M. A. Maestro, S. F. Boj, A. Paniagua, R. Casamitjana, R. Gomis, F. Rivera, and J. Ferrer
Hepatic Nuclear Factor 1-{alpha} Directs Nucleosomal Hyperacetylation to Its Tissue-Specific Transcriptional Targets
Mol. Cell. Biol.,
May 1, 2001;
21(9):
3234 - 3243.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. J. Bischof, C. C. Martin, C. A. Svitek, B. T. Stadelmaier, L. A. Hornbuckle, J. K. Goldman, J. K. Oeser, J. C. Hutton, and R. M. OBrien
Characterization of the Mouse Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein Gene Promoter by In Situ Footprinting: Correlation With Fusion Gene Expression in the Islet-Derived {beta}TC-3 and Hamster Insulinoma Tumor Cell Lines
Diabetes,
March 1, 2001;
50(3):
502 - 514.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Schmoll, K. S. Walker, D. R. Alessi, R. Grempler, A. Burchell, S. Guo, R. Walther, and T. G. Unterman
Regulation of Glucose-6-phosphatase Gene Expression by Protein Kinase Balpha and the Forkhead Transcription Factor FKHR. EVIDENCE FOR INSULIN RESPONSE UNIT-DEPENDENT AND -INDEPENDENT EFFECTS OF INSULIN ON PROMOTER ACTIVITY
J. Biol. Chem.,
November 10, 2000;
275(46):
36324 - 36333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ben-Shushan, S. Marshak, M. Shoshkes, E. Cerasi, and D. Melloul
A Pancreatic beta -Cell-specific Enhancer in the Human PDX-1 Gene Is Regulated by Hepatocyte Nuclear Factor 3beta (HNF-3beta ), HNF-1alpha , and SPs Transcription Factors
J. Biol. Chem.,
May 11, 2001;
276(20):
17533 - 17540.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|